Cargando…
DNA Methylation as a Biomarker for Cardiovascular Disease Risk
BACKGROUND: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). METHODOLOGY/PRINCIPAL FIN...
Autores principales: | Kim, Myungjin, Long, Tiffany I., Arakawa, Kazuko, Wang, Renwei, Yu, Mimi C., Laird, Peter W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837739/ https://www.ncbi.nlm.nih.gov/pubmed/20300621 http://dx.doi.org/10.1371/journal.pone.0009692 |
Ejemplares similares
-
Analysis of repetitive element DNA methylation by MethyLight
por: Weisenberger, Daniel J., et al.
Publicado: (2005) -
DNA methylation biomarkers of myocardial infarction and cardiovascular disease
por: Fernández-Sanlés, Alba, et al.
Publicado: (2021) -
Analysis of the Association between CIMP and BRAF(V600E) in Colorectal Cancer by DNA Methylation Profiling
por: Hinoue, Toshinori, et al.
Publicado: (2009) -
A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events
por: Cappozzo, Andrea, et al.
Publicado: (2022) -
Cardiovascular disease biomarkers derived from circulating cell-free DNA methylation
por: Cuadrat, Rafael R C, et al.
Publicado: (2023)